Loading…
Live Good Inc. was cited for marketing "Berry Gen Sugar Control" as an unapproved new drug through their website, social media platforms (Facebook and Instagram), and Amazon storefront by making disease claims including that the product helps reduce blood sugar levels, control diabetes, regulate insulin, and protect the pancreas. The company violated the Federal Food, Drug, and Cosmetic Act by establishing through these marketing channels that the product was intended for the cure, mitigation, treatment, or prevention of disease without FDA approval. The FDA and Federal Trade Commission jointly reviewed the company's online sales platforms in August 2021 and determined the product claims established it as a drug requiring premarket approval before introduction into interstate commerce.